Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical features, treatment response, and long-term outcomes of...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2022-12-01
Serie:	Annals of Medicine
Soggetti:	Chronic phase chronic myeloid leukaemia adolescents and young adults tyrosine kinase inhibitors Dasatinib Nilotinib
Accesso online:	https://www.tandfonline.com/doi/10.1080/07853890.2022.2069280
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!